$0.11 0.00 (0.00%) CEL-SCI Corp (New) - NYSE Amex Equities

Dec. 2, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 0.11
Trade Time: Dec 02 04:00 PM Eastern Daylight Time
Change: +0.00 (0.00%)
Prev Close: 0.11
Open: 0.12
Bid: 0.11
Ask: 0.12
  1. No results found.
  1. CEL-SCI's Rheumatoid Arthritis Vaccine Selected for Commercialization & Program Niche Analysis Plan by U.S. National Institutes of Health

    Benzinga | Nov. 4, 2015 | 10:04AM EST
  2. CEL-SCI Reports September Patient Enrollment for Its Phase 3 Head and Neck Cancer Trial

    Benzinga | Oct. 1, 2015 | 07:32AM EST
  3. CEL-SCI Expands Its Phase I Study for Treatment of Anal Warts in HIV/HPV Co-Infected Patients with Addition of 2nd Site at University of California San Francisco

    Benzinga | Jul. 20, 2015 | 07:32AM EST
  4. CEL-SCI Reports June Patient Enrollment in Its Phase 3 Head and Neck Cancer Trial

    Benzinga | Jul. 1, 2015 | 08:20AM EST
  5. CEL-SCI Announces Proposed Public Offering of Common Stock and Warrants

    Benzinga | May. 21, 2015 | 15:33PM EST
  6. CEL-SCI Reports 2nd Consecutive Month of Record Patient Enrollment in 2015 for Its Phase III Head and Neck Cancer Trial

    Benzinga | Mar. 3, 2015 | 08:15AM EST
  7. Updated Coverage Report Focuses on CEL-SCI Corporation

    GuruFocus | Jan. 12, 2015 | 11:02AM EST
  8. CEL-SCI Quarterly Patient Enrollment In Its Head And Neck Cancer Phase III Trial Increases Eight Fold Over Same Prior Year Period

    Benzinga | Dec. 2, 2014 | 08:31AM EST
  9. CEL-SCI Enrolls 22 Patients During October In Its Phase III Immunotherapy Head And Neck Cancer Trial

    Benzinga | Nov. 3, 2014 | 08:33AM EST
  10. Morning Market Losers

    Benzinga | Apr. 14, 2014 | 08:48AM EST
  11. Morning Gainers for Friday, March 14, 2014

    Benzinga | Mar. 14, 2014 | 09:09AM EST
  12. Mid-Day Gainers Mar. 7, 2014: SKUL, SMSI, DLIA, BIG, CVM, KFY, GTAT

    Benzinga | Mar. 7, 2014 | 11:26AM EST
  13. Morning Movers for Mar. 7, 2014: SKUL, DLIA, BIG, GTAT, CCRN, FL Moving Higher; NLNK, FEYE, SWY, FCEL Lower

    Benzinga | Mar. 7, 2014 | 09:04AM EST
  14. CEL-SCI Says Navy Okays Commencement of Co.'s Phase I Trial for Treatment of Anal Warts in HIV/HPV Co-Infected Patients

    Benzinga | Feb. 3, 2014 | 08:41AM EST
  15. CEL-SCI Prices $3.0M Unit at $0.63/Unit

    Benzinga | Dec. 19, 2013 | 09:21AM EST
Trading Center